Search research articles
Contact Us
Filters
Showing results (21-30 of 93) with videos related to
Page
of 10
Sort By:
Frontiers in Oncology
|
June 26, 2026
Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myeloma
Giuseppe Bertuglia, Alessandro Di Nicola, Francesca Gay, et al.
Expert Review of Anticancer Therapy
|
April 18, 2014
Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data
Massimo Offidani, Laura Corvatta, Patrizia Caraffa, et al.
Expert Review of Anticancer Therapy
|
June 7, 2008
Lenalidomide and its role in the management of multiple myeloma
Patrizia Falco, Federica Cavallo, Alessandra Larocca, et al.
Cancer Treatment and Research
|
October 4, 2016
Treatment of Newly Diagnosed Elderly Multiple Myeloma
Guillemette Fouquet, Francesca Gay, Eileen Boyle, et al.
Current Hematologic Malignancy Reports
|
April 29, 2010
Treatment of newly diagnosed multiple myeloma
Antonio Palumbo, Valeria Magarotto, Alessandra Larocca, et al.
European Journal of Haematology
|
November 29, 2016
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma
Massimo Offidani, Laura Corvatta, Sara Bringhen, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
August 19, 2022
Melphalan flufenamide for relapsed/refractory multiple myeloma
Omar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 16, 2004
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia
Fausto Rossini, Elisabetta Terruzzi, Luisa Verga, et al.
Frontiers in Immunology
|
January 6, 2023
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status
Claudia Giannotta, Barbara Castella, Ezio Tripoli, et al.
Expert Opinion on Investigational Drugs
|
September 14, 2020
Melflufen for relapsed and refractory multiple myeloma
Albert Oriol, Alessandra Larocca, Xavier Leleu, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 93) with videos related to
Sort By:
Page
of 10
Frontiers in Oncology
|
June 26, 2026
Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myeloma
Giuseppe Bertuglia, Alessandro Di Nicola, Francesca Gay, et al.
Expert Review of Anticancer Therapy
|
April 18, 2014
Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data
Massimo Offidani, Laura Corvatta, Patrizia Caraffa, et al.
Expert Review of Anticancer Therapy
|
June 7, 2008
Lenalidomide and its role in the management of multiple myeloma
Patrizia Falco, Federica Cavallo, Alessandra Larocca, et al.
Cancer Treatment and Research
|
October 4, 2016
Treatment of Newly Diagnosed Elderly Multiple Myeloma
Guillemette Fouquet, Francesca Gay, Eileen Boyle, et al.
Current Hematologic Malignancy Reports
|
April 29, 2010
Treatment of newly diagnosed multiple myeloma
Antonio Palumbo, Valeria Magarotto, Alessandra Larocca, et al.
European Journal of Haematology
|
November 29, 2016
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma
Massimo Offidani, Laura Corvatta, Sara Bringhen, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
August 19, 2022
Melphalan flufenamide for relapsed/refractory multiple myeloma
Omar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 16, 2004
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia
Fausto Rossini, Elisabetta Terruzzi, Luisa Verga, et al.
Frontiers in Immunology
|
January 6, 2023
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status
Claudia Giannotta, Barbara Castella, Ezio Tripoli, et al.
Expert Opinion on Investigational Drugs
|
September 14, 2020
Melflufen for relapsed and refractory multiple myeloma
Albert Oriol, Alessandra Larocca, Xavier Leleu, et al.
Page
of 10